Evaluation of Immunomodulatory Receptor/Ligand Expression on Matched Human Biospecimens
Utility of Biomarkers to Differentiate Adenocarcinoma Of The Uterine Cervix from Its Mimics
Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinomas Show a Marked Increase in PDL1 Expression Relative to Viral Negative Tumors
Multi-Parametric Flow Cytometry Analysis of Checkpoint Inhibitors (PD-1 and PD-L1) in Dissociated Tumor and Normal Tissues
Exploring Dissociated Human Tissues as an Alternative to Fresh Tissue for Multiple Downtstream Applications
Discovery Life Sciences advances science in an innovative, collaborative, and client-centric environment. We are grounded in a “Science at your Service” attitude.
Learn More »
Discovery Life Sciences provides the world class biospecimen analysis and procurement needed to advance modern drug and biomarker discoveries.
Terms & Conditions » Biospecimen Purchase Agreement » Data Use Agreement »
Leading Research Sample bioBank with online easy-ordering for Human Biospecimens and Immediate Overnight Delivery
Terms & Conditions »
T: +01 (866) 838-2798 E: email@example.com
© 2020 Discovery Life Sciences.
All Rights Reserved.
Checkpoint Inhibitor Therapy Utilization and PD1/PDL1 Expression Across a Global Clinical Network.
Put Discovery Partners® to Work for You
The Discovery Partners platform is a global, integrated network. We collaborate with these clinical partners to fulfill human biospecimen research needs.
firstname.lastname@example.org (866) 838-2798